secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonnet BioTherapeutics Holdings, Inc. (—)
CIK:        0001106838
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001641172-25-013264
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

SONN reports stockholders' equity of $662K, below Nasdaq $2.5M minimum; faces delisting risk
--------------------------------------------------------------------------------

- Stockholders' equity of $662,262 as of March 31, 2025, well below the $2.5M minimum for continued Nasdaq listing.
- Must submit a compliance plan by July 14, 2025; Nasdaq may grant an up to 180-day extension if plan accepted.
- Also fails alternative compliance measures: market value of listed securities <$35M and no net income >$500K.
- No immediate effect on trading; common stock (SONN) continues on Nasdaq Capital Market.
- Delisting would materially hurt capital raising, liquidity, and stock value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106838/000164117225013264/0001641172-25-013264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106838/000164117225013264/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer